Preprogrammed insulin infusion with a portable pump system
- PMID: 119699
Preprogrammed insulin infusion with a portable pump system
Abstract
A glucose-controlled insulin infusion system (Biostator) was used to determine patient insulin requirement for clinical evaluation of a portable pump system (technical development by Siemens AG). Results from 6 insulin-dependent diabetics with respect to quality of control, carbohydrate/insulin ratio, and insulin requirement are shown. Preprogrammed insulin infusion with the portable system was carried out for up to 117 days.
Similar articles
-
Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.Horm Metab Res Suppl. 1979;(8):207-11. Horm Metab Res Suppl. 1979. PMID: 395083
-
A portable, pre-programmable insulin infusion system in diabetes mellitus.Horm Metab Res Suppl. 1979;(8):191-3. Horm Metab Res Suppl. 1979. PMID: 395078
-
Continuous intravenous insulin therapy with a miniaturized open-loop system.Horm Metab Res Suppl. 1979;(8):186-90. Horm Metab Res Suppl. 1979. PMID: 395077
-
Insulin treatment: a non-stop revolution.Diabetologia. 1983 Sep;25(3):209-21. doi: 10.1007/BF00279931. Diabetologia. 1983. PMID: 6357909 Review. No abstract available.
-
Continuous subcutaneous insulin infusion: a developing tool in diabetes research.Diabetologia. 1980 Jan;18(1):1-4. doi: 10.1007/BF01228294. Diabetologia. 1980. PMID: 6988262 Review. No abstract available.